Form 4: CalciMedica Insider Reports Stock Option Activity

CalciMedica, Inc. (CALC) insider Sudarshan Hebbar reports on stock option transactions, detailing vesting schedules and potential future equity.

Summary

• Sudarshan Hebbar, Chief Medical Officer at CalciMedica, Inc., has filed a Form 4 detailing transactions related to employee stock options.
• The filing indicates an employee stock option with an exercise price of $0.585, granting the right to buy common stock.
• A total of 91,173 shares are subject to this option.
• Vesting begins on April 1, 2026, with 1/48th of the shares vesting monthly over a four-year period.
• Vesting is contingent upon the company filing a registration statement on Form S-8 for shares added to the 2023 Equity Incentive Plan.
• The transaction date is noted as April 5, 2026, with the report filed on April 7, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details standard executive compensation and insider transactions without immediate financial performance indicators or significant strategic shifts.

Positives

• The filing indicates continued engagement and equity incentives for key management personnel, such as the Chief Medical Officer.
• The existence of stock options suggests a mechanism for aligning management's interests with those of shareholders.
• The vesting schedule, spanning four years, promotes long-term commitment from the executive.

Negatives

• Vesting is contingent on the filing of a Form S-8, which has not yet occurred, indicating a potential delay in the executive's ability to exercise these options.
• The exercise price of $0.585 suggests that the current market price of the stock may be at or below this level, or that the option was granted at a time when the stock price was lower.

Risks

• The primary risk is the dependency of option vesting on the company's ability to file the Form S-8 registration statement, which could be subject to regulatory or internal delays.
• If the company's stock price does not appreciate significantly above the $0.585 exercise price, the options may not provide substantial financial benefit to the reporting person.

Future Outlook

The future outlook for the stock options is dependent on the company's successful filing of the Form S-8 registration statement and the subsequent appreciation of CalciMedica's common stock above the $0.585 exercise price.

Management Comments

• Vesting is contingent upon the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual 'evergreen' provision.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for tracking insider transactions, particularly stock options, which are common compensation tools in the biotechnology and pharmaceutical sectors like CalciMedica's. The contingent vesting tied to an S-8 filing is a specific detail that warrants attention regarding the company's administrative and regulatory processes.

Stakeholder Impact

• Shareholders: The filing confirms ongoing equity incentives for management, which can align interests, but the contingent vesting adds a layer of uncertainty.
• Employees: The existence of the 2023 Equity Incentive Plan, as referenced, suggests a broader framework for employee compensation, though specific details for other employees are not provided.
• Management (Sudarshan Hebbar): The filing details potential future compensation tied to company performance and regulatory compliance.

Next Steps

• CalciMedica must file the Form S-8 registration statement for the shares to become eligible for vesting.
• Sudarshan Hebbar will be eligible to exercise the vested portion of the stock options as per the monthly vesting schedule, starting April 1, 2026, once the S-8 is filed.
• Shareholders will monitor the company's progress in filing the S-8 and the subsequent stock performance relative to the option exercise price.

Key Dates

Keywords

Form 4, CalciMedica, CALC, Sudarshan Hebbar, Stock Option, Employee Stock Option, Beneficial Ownership, SEC Filing, Equity Incentive Plan, Vesting Schedule, Form S-8